Written by:

Dale Conlon

Medically Reviewed by:

Dimitra Theofili

Last Updated:

July 20th, 2026

Opiate withdrawal and detox

Opioid dependence does not have a single face. It includes the person who was prescribed codeine after a back injury and quietly found they could not stop. It includes the teenager who progressed from tramadol to heroin in the space of a year. It includes the professional who has been buying oxycodone online for months and has told nobody. It includes the individual whose illicit supply now routinely contains fentanyl, whether they know it or not. The routes into opioid dependence are as varied as the people it affects, but the underlying neurobiology is the same, and the need for detox applies equally to all of them.

Opioid detox is the medically supported process of safely discontinuing opioid use while the brain’s endogenous opioid system, profoundly suppressed by chronic external input, is given the clinical support it needs to begin functioning independently again. While opioid withdrawal is not typically life-threatening in the way that alcohol or benzodiazepine withdrawal can be, it is one of the most physically punishing drug withdrawal syndromes, and attempting it without professional support almost always ends in relapse, often within hours.

Opioids are a broad class of substances, natural, semi-synthetic, and fully synthetic, that all act on the brain’s opioid receptor system. They range from drugs with a long medical history to compounds that have appeared only in the last decade, and from substances available over the counter to those that exist almost entirely in the illicit market. What unites them is their mechanism: every opioid, regardless of its origin, produces dependence through the same receptor pathway and generates the same fundamental withdrawal syndrome when removed.

This diversity matters clinically. The specific opioid, its potency, its half-life, the dose, the duration of use, and the route of administration all shape the withdrawal timeline, its severity, and the optimal approach to detox. A person withdrawing from a twenty-year codeine habit presents a very different clinical picture from someone withdrawing from intravenous fentanyl, even though the underlying neurobiology is shared.

At Banbury Lodge, we offer detox on the following opiates;

One of the defining features of the opioid crisis, in the UK as elsewhere, is the sheer range of pathways through which people arrive at dependence. Understanding these pathways matters because they shape not only the clinical presentation at the point of detox but also the psychological and social dimensions of treatment.

The human brain produces its own opioid molecules, the endorphins and enkephalins, which act on a family of opioid receptors (principally the mu, delta, and kappa receptors) distributed throughout the central and peripheral nervous systems. This endogenous opioid system is involved in pain modulation, mood regulation, stress response, reward processing, and the regulation of autonomic functions including gut motility and respiration.

Every external opioid, whether codeine or fentanyl, works by binding to the mu-opioid receptor (μ-receptor) with an affinity and potency that vastly exceeds the brain’s own supply. This produces the class’s defining effects: analgesia, euphoria, anxiolysis, sedation, and respiratory depression. With chronic exposure, the brain mounts the same adaptive response it deploys against any sustained pharmacological overstimulation:

• Mu-receptor downregulation: Receptor numbers are reduced and their sensitivity diminished, producing tolerance: the need for ever-increasing doses to achieve the same effect.
• Endorphin and enkephalin suppression: The brain’s own opioid production falls dramatically. The system designed to provide natural pain relief, emotional stability, and a sense of wellbeing effectively shuts down because the external supply has made it redundant.
• Noradrenergic hyperactivation: The locus coeruleus, a brainstem nucleus rich in noradrenaline-producing neurons that is normally suppressed by opioid input, becomes chronically hyperactive once that suppression is withdrawn. This noradrenergic rebound is responsible for many of the most recognisable physical symptoms of opioid withdrawal: sweating, goosebumps, tachycardia, hypertension, diarrhoea, and the characteristic feeling of crawling skin.
• Reward circuitry recalibration: The mesolimbic dopamine system, hijacked by chronic opioid stimulation, becomes unable to generate normal reward signalling in the absence of the drug. The result is the profound anhedonia, motivational collapse, and dysphoria that characterise opioid withdrawal and early recovery.
• Anti-reward system activation: Chronic opioid use activates stress-mediating systems including dynorphin signalling and corticotropin-releasing factor (CRF), which produce a state of persistent negative affect that drives compulsive drug-seeking even beyond the resolution of physical withdrawal.

When opioids are removed, the full extent of these adaptations is revealed. The brain has no endogenous opioid buffer, an overactive stress system, a silenced reward pathway, and an autonomic nervous system in unrestrained overdrive. This is what opioid withdrawal feels like from the inside, and it is why, for the person experiencing it, the only thought in the world is the one telling them to make it stop.

Opioid withdrawal has been described as the worst flu of your life multiplied by the worst anxiety of your life, experienced simultaneously and without any sense of when it will end. It is not typically life-threatening (with important exceptions for medically compromised individuals and specific populations), but it is so intensely, relentlessly unpleasant that it drives relapse in the overwhelming majority of unsupported attempts. Severity is determined by the specific opioid, its dose, the duration of use, the route of administration, and individual variation.

The Symptoms of Opioid Withdrawal

• Intense drug cravings: Overwhelming, single-minded urges to use that dominate every other thought. These are driven by both the neurobiological pain of withdrawal and the deeply encoded reward memory of relief.
• Muscle and bone pain: Diffuse, deep aching in the muscles, joints, and bones. The removal of opioid analgesia unmasks both the pain the drug was suppressing and a rebound hyperalgesia (heightened pain sensitivity) driven by neuroadaptive changes.
• Gastrointestinal distress: Nausea, vomiting, abdominal cramping, and diarrhoea. Opioids suppress gut motility; their removal produces a violent autonomic rebound that makes gastrointestinal symptoms one of the most physically debilitating features of withdrawal. Dehydration is a genuine risk.
• Sweating, chills, and goosebumps: Thermoregulatory chaos as the autonomic nervous system oscillates without opioid modulation. The characteristic ‘cold turkey’ gooseflesh (piloerection) that gave the phenomenon its colloquial name.
• Insomnia and restlessness: Profound inability to sleep, combined with a physical restlessness that makes it impossible to lie still. Restless legs syndrome is common and can be maddening.
• Anxiety and agitation: Acute anxiety, panic, irritability, and a pervasive sense of impending catastrophe, driven by noradrenergic and CRF system hyperactivation.
• Depression and dysphoria: Profound low mood, hopelessness, and an absolute inability to imagine feeling pleasure again.
• Yawning, lacrimation, and rhinorrhoea: Excessive yawning, watery eyes, and a streaming nose are early indicators of opioid withdrawal, often appearing before the more severe symptoms develop.
• Pupil dilation (mydriasis): A reliable clinical marker of opioid withdrawal, reflecting autonomic nervous system rebound.

The withdrawal timeline varies significantly depending on the specific opioid’s half-life:

Tramadol: An Atypical Withdrawal

Tramadol occupies an unusual position within the opioid class because it has a dual mechanism of action: it is both a mu-opioid receptor agonist and a serotonin-norepinephrine reuptake inhibitor (SNRI). This means that tramadol withdrawal can include symptoms not typically seen with other opioids, including serotonergic features such as confusion, agitation, tremor, and, in rare cases, seizures. Tramadol withdrawal requires specific clinical awareness and should not be assumed to follow the same course as withdrawal from pure opioid agonists.

Opioid detox is supported by one of the most established and effective medical treatment approaches in addiction medicine. Unlike withdrawal from some other substances, where treatment focuses primarily on managing symptoms, opioid detox can involve medications that act directly on the brain’s opioid receptors. These medications help reduce withdrawal symptoms, ease cravings, and allow the body to adjust more gradually as it becomes opioid-free. The most appropriate detox approach depends on several factors, including the type of opioid being used, the severity and duration of dependence, the individual’s overall health, and their longer-term recovery goals.

Throughout detox, progress is carefully monitored using the Clinical Opiate Withdrawal Scale (COWS), a widely recognised assessment tool that measures the severity of opioid withdrawal. The scale evaluates a range of physical and psychological symptoms, including pulse rate, sweating, restlessness, pupil size, bone and joint aches, gastrointestinal upset, tremor, yawning, anxiety, and gooseflesh (piloerection). Regular COWS assessments help the clinical team determine when medication should be started or adjusted, identify any emerging complications early, and provide an objective measure of withdrawal alongside the person’s own experience. This allows treatment to remain responsive throughout the detox process, helping to maximise comfort and safety.

Opioid detox can be carried out in either a residential (inpatient) or community (outpatient) setting. The most appropriate option depends on several factors, including the type of opioid being used, the severity and duration of dependence, physical and mental health, any co-occurring substance use, previous detox attempts, and the individual’s home environment and support network. While outpatient detox may be suitable for some people, residential treatment offers the highest level of medical care and support, particularly for those with more complex needs.

Residential (Inpatient) Opioid Detox

Residential detox provides a safe, structured environment where withdrawal can be managed with continuous clinical care and immediate access to medical support if needed. It is often recommended for people with severe opioid dependence, those using illicit opioids where potency or contamination is uncertain, individuals with co-occurring physical or mental health conditions, and anyone who has struggled with previous detox attempts.

Key benefits of residential detox include:

• Continuous clinical monitoring: Withdrawal symptoms are regularly assessed using recognised tools such as the Clinical Opiate Withdrawal Scale (COWS), allowing medication and care to be adjusted as symptoms change.
• A drug-free environment: Being removed from access to opioids and familiar triggers reduces the risk of relapse during the most physically and emotionally challenging stage of withdrawal.
• Medical and nutritional support: Clinical teams can manage dehydration, gastrointestinal symptoms, poor appetite, and other physical effects of withdrawal while supporting recovery through adequate nutrition and hydration.
• Therapeutic support from the outset: Individual therapy, group sessions and psychoeducation begin during detox, helping people understand addiction and build coping strategies rather than waiting until withdrawal has ended.
• A seamless transition into rehabilitation: Detox is only the first step in recovery. Residential programmes allow people to move directly into structured therapy, reducing the high-risk period between detox and ongoing treatment.
• Overdose prevention education: Before discharge, individuals receive education about reduced opioid tolerance, overdose risk, and the use of naloxone where appropriate.

Community (Outpatient) Opioid Detox

Community detox is usually delivered through a GP or local drug and alcohol service and may be appropriate for people with less severe dependence, stable physical and mental health, and a strong support network at home. It allows individuals to continue living in the community while attending regular appointments and following an agreed treatment plan.

However, outpatient detox can present significant challenges. Withdrawal symptoms often make it difficult to work, care for family, or manage day-to-day responsibilities. Remaining in the same environment also means continued exposure to people, places and situations associated with opioid use, which can increase the risk of relapse. If someone returns to opioid use after even a short period of abstinence, their tolerance may have fallen, significantly increasing the risk of overdose.

For people with moderate to severe opioid dependence, residential detox generally offers the safest and most effective route into recovery. It combines expert medical care with therapeutic support and removes many of the barriers that make it difficult to complete detox successfully, laying a stronger foundation for long-term rehabilitation and sustained recovery.

The principal danger of unsupported opioid detox is not, for most people, death during withdrawal itself. It is the near-certainty of relapse and the potentially fatal consequences that follow:

• Overdose following reduced tolerance: This is the single most important risk. Even a partial period of abstinence significantly reduces opioid tolerance. An individual who relapses to their previous dose, a dose their body handled routinely days or weeks earlier, can suffer fatal respiratory depression. This risk is dramatically amplified in a market increasingly contaminated with fentanyl.
• Severe dehydration: Vomiting and diarrhoea during unsupported withdrawal can produce dangerous dehydration and electrolyte imbalance, particularly in individuals who are already nutritionally compromised.
• Psychiatric crisis: Severe depression, hopelessness, and suicidal ideation are features of opioid withdrawal and require clinical monitoring.
• Compensatory substance use: Individuals may turn to alcohol, benzodiazepines, or other sedatives to manage the insomnia and anxiety of opioid withdrawal, introducing new dependencies and potentially fatal drug combinations.
• Aspiration: Vomiting while sedated (whether from exhaustion, concurrent substance use, or relapse) carries a risk of aspiration that, without medical monitoring, can be fatal.

Opioid detox should always be conducted with medical support. The combination of the near-certain failure of unsupported attempts and the life-threatening consequences of relapse to a reduced tolerance makes professional supervision not merely advisable but essential.

The relationship between opioid dependence and mental health is deep and bidirectional. A substantial proportion of individuals who develop opioid dependence are living with depression, anxiety, PTSD, or other psychiatric conditions, and many initially discovered opioids in the course of managing physical or emotional pain. Opioids are uniquely effective at numbing not just physical pain but psychological pain: grief, trauma, loneliness, shame. The process of removing that numbing inevitably confronts the individual with the unprocessed emotional material it was suppressing, material that now surfaces alongside the neurobiological storm of withdrawal.

Effective opioid detox requires an integrated dual diagnosis approach in which psychiatric assessment, mental health monitoring, and the establishment of appropriate treatment for co-occurring conditions are woven into the detox process from the outset. Treating the opioid dependence without treating the pain, trauma, or psychiatric condition that sustained it is a formula for relapse.

Completing opioid detox is a significant physical achievement. It is also one of the most dangerous junctures in the entire recovery process, because the individual now has dramatically reduced tolerance and faces a protracted period of neurobiological vulnerability. Without structured post-detox support, the overwhelming majority of people relapse, and a relapse to full-dose use at reduced tolerance carries a very real risk of death.

Effective post-detox treatment typically includes:

• Residential rehabilitation: A structured therapeutic programme integrating individual psychotherapy, group therapy, psychoeducation, and life skills development. The immersive, substance-free environment of residential rehab is strongly associated with better outcomes for opioid dependence.
• Cognitive Behavioural Therapy (CBT): CBT is the most evidence-based psychological intervention for substance dependence, equipping individuals with practical strategies for managing cravings, triggers, and high-risk situations.
• Trauma-focused therapy: For the many individuals whose opioid use is rooted in unresolved trauma, therapies such as EMDR are essential.
• Relapse prevention and naloxone: A personalised relapse prevention plan identifying triggers and coping strategies, alongside naloxone provision and training as a critical safety net.
• Long-term aftercare: Ongoing group therapy, key-working sessions, family support, and mutual aid communities such as Narcotics Anonymous. Recovery from opioid dependence is a sustained process, and the months and years following detox require structure, connection, and support.

At Banbury Lodge, we understand that opioid dependence is as varied as the people it affects. Whether your dependence began with a prescription, an over-the-counter purchase, or the illicit market, whether the drug is codeine, tramadol, oxycodone, heroin, fentanyl, or methadone, we have the clinical expertise and the compassion to help you through detox and into lasting recovery.

Our experienced clinical team provides:

• Comprehensive assessment of the opioid(s) involved, dose, duration of use, physical health, mental health, and social circumstances
• Evidence-based detox protocols using buprenorphine, methadone, lofexidine, and symptomatic medications, individually tailored to each clinical presentation
• Continuous nursing support and medical monitoring throughout the withdrawal process
• Psychiatric assessment and integrated dual diagnosis care from day one
• Psychological support beginning during detox, with therapy and the medical programme running in parallel
• Naloxone training and take-home provision for every individual and their family
• A structured pathway into residential rehabilitation immediately following detox
• A comprehensive aftercare package including ongoing therapy, relapse prevention, and long-term support

Opioid dependence is isolating, exhausting, and frightening. Recovery is possible, and it begins with a single decision. If you or someone you care about is ready, contact us today.